Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

2.

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A.

Diabetologia. 2008 Jun;51(6):941-51. doi: 10.1007/s00125-008-0974-3. Epub 2008 Mar 20. Review.

PMID:
18351320
3.

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N.

Health Technol Assess. 2004 Oct;8(43):iii, 1-171. Review.

4.

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.

Farrar D, Tuffnell DJ, West J, West HM.

Cochrane Database Syst Rev. 2016 Jun 7;(6):CD005542. doi: 10.1002/14651858.CD005542.pub3. Review.

PMID:
27272351
5.

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.

Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N.

Health Technol Assess. 2010 Feb;14(11):iii-iv, xi-xvi, 1-181. doi: 10.3310/hta14110. Review.

6.

Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.

Thabit H, Hovorka R.

Expert Opin Drug Deliv. 2016;13(3):389-400. doi: 10.1517/17425247.2016.1115013. Epub 2015 Nov 30. Review.

PMID:
26618219
7.
8.

Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis.

Ranasinghe PD, Maruthur NM, Nicholson WK, Yeh HC, Brown T, Suh Y, Wilson LM, Nannes EB, Berger Z, Bass EB, Golden SH.

J Womens Health (Larchmt). 2015 Mar;24(3):237-49. doi: 10.1089/jwh.2014.4939. Epub 2015 Feb 25. Review.

9.

Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.

Roze S, Smith-Palmer J, Valentine W, de Portu S, Nørgaard K, Pickup JC.

Diabet Med. 2015 Nov;32(11):1415-24. doi: 10.1111/dme.12792. Epub 2015 May 28. Review.

PMID:
25962621
10.

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.

Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005103. doi: 10.1002/14651858.CD005103.pub2. Review.

PMID:
20091571
11.

Continuous subcutaneous insulin infusion (CSII) pumps.

Valla V.

Adv Exp Med Biol. 2012;771:414-9. Review.

PMID:
23393693
12.

Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.

Bruttomesso D, Costa S, Baritussio A.

Diabetes Metab Res Rev. 2009 Feb;25(2):99-111. doi: 10.1002/dmrr.931. Review.

PMID:
19172576
13.

Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.

Potti LG, Haines ST.

J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):e1-13; quiz e14-7. doi: 10.1331/JAphA.2009.08122. Review.

PMID:
19196588
14.

Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.

Kaiserman K, Rodriguez H, Stephenson A, Wolka L, Fahrbach JL.

Endocr Pract. 2012 May-Jun;18(3):418-24. doi: 10.4158/EP11265.RA. Review.

PMID:
22297055
15.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
16.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
17.

[Insulin pump therapy in patients with type 1 diabetes].

Minicucci WJ.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):340-8. Review. Portuguese.

18.

Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.

Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.

Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170. Review.

19.

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

King AB, Kuroda A, Matsuhisa M, Hobbs T.

Curr Diab Rep. 2016 Sep;16(9):83. doi: 10.1007/s11892-016-0772-0. Review.

Supplemental Content

Support Center